Literature DB >> 32139561

Complete Coding Sequence of a Novel Bluetongue Virus Isolated from a Commercial Sheeppox Vaccine.

Paulina Rajko-Nenow1, Natalia Golender2, Velizar Bumbarov2, Hannah Brown3, Lorraine Frost3, Karin Darpel3, Chandana Tennakoon3, John Flannery3, Carrie Batten3.   

Abstract

The full genome sequences of two isolates of bluetongue virus (BTV) from a commercial sheeppox vaccine were determined. Strain SPvvvv/02 shows low sequence identity to its closest relative, strain BTV-26 KUW2010/02, indicating the probable detection of a novel BTV genotype, whereas strain SPvvvv/03 shows high sequence identity to strain BTV-28/1537/14.
Copyright © 2020 Rajko-Nenow et al.

Entities:  

Year:  2020        PMID: 32139561      PMCID: PMC7171223          DOI: 10.1128/MRA.01539-19

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Bluetongue (BT) is a disease of ruminants which is transmitted by blood-feeding Culicoides midges (1). BT is one of the major diseases of ruminants listed by the World Organisation for Animal Health (OIE), and suspicion of disease needs to be reported to veterinary authorities. BT virus (BTV) belongs to the Orbivirus genus, and its genome consists of 10 linear double-stranded RNA segments encoding seven structural (VP1 to VP7) and five nonstructural (NS1 to NS5) proteins (2, 3). While the typical BTV genotypes (BTV-1 through BTV-24) are noncontagious and almost exclusively transmitted via their biological insect vector, Culicoides biting midges, direct transmission between infected animals has been documented for the atypical genotypes BTV-25, BTV-26, BTV-27, and BTV-28 (4–7). BTV contamination of commercial batches of sheeppox and lumpy skin disease vaccines was previously reported (8). However, full-genome sequencing data were incomplete in this study and were limited to only a few segments. A subsequent study released the full genome sequence and demonstrated that the sheeppox vaccine-derived BTV-28 strain (BTV-28/1537/14) caused clinical signs in experimentally infected ewes and could be directly transmitted between infected and healthy sheep (7). The commercial sheeppox vaccine (JOVAC, batch number 200214/01) was resuspended in 1 ml phosphate-buffered saline (PBS; pH 7.20) and used as the inoculum for virus propagation in baby hamster kidney (BHK) cells. Total RNA was extracted from the cell pellets using TRIzol reagent (Life Technologies, UK). Single-stranded RNA (ssRNA) was removed by RNase T1 digestion, and then double-stranded DNA (dsDNA) synthesis was performed using SuperScript III reverse transcriptase (RT) (Life Technologies) and the NEBNext Ultra II nondirectional RNA second-strand synthesis module (New England Biolabs, UK) according to the manufacturer’s instructions. Library preparation was performed using the Nextera XT DNA library kit (Illumina, USA), and paired-end read sequencing (2 × 150 bp) was carried out using an Illumina MiSeq instrument. The raw data were quality (with the parameter -q 25) and adapter trimmed along with the removal of short sequences (<50 bp) using Trim Galore (9). Paired-end reads were mapped to a set of reference genomes using Bowtie2 version 2.2.9 (10) with the “relax” setting to increase sensitivity. Local alignment was performed using a short seed (–15), allowing for one mismatch in the seed. The DiversiTools software (11) was used to generate the consensus sequence. Subsequently, the best consensus sequences (without any gaps) were used as the reference sequence (Table 1) for each segment, and the reads were mapped using BWA-MEM version 0.7.12-r1039 (12). In addition, the consensus sequences generated from BWA-MEM mapping were compared to those generated using in-house de novo mapping (unpublished protocol), but no changes were identified.
TABLE 1

Sequencing data for isolates SPvvvv/02 and SPvvvv/03

IsolateaGenBank accession no.Segment no.Length (bp)No. of mapped readsAvg depth (bp)Reference sequence nameReference sequence accession no.Nucleotide identity (%)
SPvvvv/02MN72387013,944202,3617,104BTV-26 KUW2010/02JN25515692.7
MN72387122,928142,9926,746BTV-26 KUW2010/02HM59064272.5
MN72387232,766136,5326,711TUN2017MF12428499.7
MN72387341,98277,6045,311TUN2017MF124285100.0
MN72387451,76863,5874,885BTV-28/1537/14MH55981298.1
MN72387561,62973,3536,157BTV-26 KUW2010/02JN25515988.0
MN72387671,15725,4742,912BTV-26 KUW2010/02HM59064491.8
MN72387781,12123,3762,742BTV-28/1537/14MH55981098.1
MN72387891,06437,4814,400TUN2017MF12429099.8
MN723879b108227,9991,272BTV-26 KUW2010/02JN25516287.2
SPvvvv/03MN72388013,944440,73115,666BTV-28/1537/14MH55981399.9
MN72388122,925264,35812,595BTV-28/1537/14MH55980799.9
MN72388232,773342,22516,928BTV-28/1537/14MH559808100.0
MN72388341,982199,95113,802BTV-28/1537/14MH559814100.0
MN72388451,766186,85214,099BTV-28/1537/14MH55981299.9
MN72388561,639316,53626,612BTV-28/1537/14MH559815100.0
MN72388671,15755,2726,213BTV-28/1537/14MH559811100.0
MN72388781,12163,5817,428BTV-28/1537/14MH559810100.0
MN72388891,06479,0399,272BTV-28/1537/14MH55981699.9
MN723889b1082212,0421,866BTV-28/1537/14MH559809100.0

The entire genome of SPvvvv/02 (segments 1 through 10) has a segment length of 19,181 bp, 790,759 mapped reads, and an average coverage depth of 4,824 bp, and the entire genome of SPvvvv/03 (segments 1 through 10) has a segment length of 19,193 bp, 1,960,587 mapped reads, and an average coverage depth of 12,448 bp.

BTV segment 10 (GenBank accession number KT946752) was first sequenced directly using RNA extracted from a commercial sheeppox vaccine (8); it had 100% nucleotide identity with SPvvvv/02 and 98.39% identity with both SPvvvv/03 and BTV-28/1537/14.

Sequencing data for isolates SPvvvv/02 and SPvvvv/03 The entire genome of SPvvvv/02 (segments 1 through 10) has a segment length of 19,181 bp, 790,759 mapped reads, and an average coverage depth of 4,824 bp, and the entire genome of SPvvvv/03 (segments 1 through 10) has a segment length of 19,193 bp, 1,960,587 mapped reads, and an average coverage depth of 12,448 bp. BTV segment 10 (GenBank accession number KT946752) was first sequenced directly using RNA extracted from a commercial sheeppox vaccine (8); it had 100% nucleotide identity with SPvvvv/02 and 98.39% identity with both SPvvvv/03 and BTV-28/1537/14. The full genome sequences of the two isolates, SPvvvv/02 and SPvvvv/03, were obtained from the sheeppox vaccine. SPvvvv/02 showed only 72.5% and 88.0% nucleotide identity to its closest relative, BTV-26 KUW2010/02, in segments 2 and 6, respectively (Table 1). This finding indicates the detection of a putative novel genotype of BTV. In contrast, SPvvvv/03 was highly identical to strain BTV-28/1537/14 across all 10 segments (99.86% to 100%), but its segment 1 was slightly shorter (3,944 bp) in comparison with that of BTV-28/1537/14 (3,985 bp). Our study indicates that the commercial sheeppox vaccine was contaminated with more than one novel BTV genotype.

Data availability.

The full genome sequences of isolates SPvvvv/02 and SPvvvv/03 have been deposited in GenBank under accession numbers MN723870 through MN723879 and MN723880 through MN723889, respectively. The raw sequencing reads have been deposited in the NCBI SRA under BioProject accession number PRJNA599340.
  10 in total

Review 1.  The pathology and pathogenesis of bluetongue.

Authors:  N J Maclachlan; C P Drew; K E Darpel; G Worwa
Journal:  J Comp Pathol       Date:  2009-05-23       Impact factor: 1.311

2.  Characterization of bluetongue virus serotype 28.

Authors:  Velizar Bumbarov; Natalia Golender; Maria Jenckel; Kerstin Wernike; Martin Beer; Evgeny Khinich; Olga Zalesky; Oran Erster
Journal:  Transbound Emerg Dis       Date:  2019-09-10       Impact factor: 5.005

3.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

4.  Detection and isolation of Bluetongue virus from commercial vaccine batches.

Authors:  Velizar Bumbarov; Natalia Golender; Oran Erster; Yevgeny Khinich
Journal:  Vaccine       Date:  2016-05-09       Impact factor: 3.641

5.  One after the other: A novel Bluetongue virus strain related to Toggenburg virus detected in the Piedmont region (North-western Italy), extends the panel of novel atypical BTV strains.

Authors:  Maurilia Marcacci; Serena Sant; Iolanda Mangone; Maria Goria; Alessandro Dondo; Simona Zoppi; René G P van Gennip; Maria Cristina Radaelli; Cesare Cammà; Piet A van Rijn; Giovanni Savini; Alessio Lorusso
Journal:  Transbound Emerg Dis       Date:  2018-02-02       Impact factor: 5.005

6.  Bluetongue virus serotype 27: Experimental infection of goats, sheep and cattle with three BTV-27 variants reveal atypical characteristics and likely direct contact transmission BTV-27 between goats.

Authors:  E Bréard; C Schulz; C Sailleau; C Bernelin-Cottet; C Viarouge; D Vitour; B Guillaume; G Caignard; A Gorlier; H Attoui; M Gallois; B Hoffmann; S Zientara; M Beer
Journal:  Transbound Emerg Dis       Date:  2017-12-15       Impact factor: 5.005

7.  Evidence for transmission of bluetongue virus serotype 26 through direct contact.

Authors:  Carrie Batten; Karin Darpel; Mark Henstock; Petra Fay; Eva Veronesi; Simon Gubbins; Samantha Graves; Lorraine Frost; Christopher Oura
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

8.  Fast and accurate long-read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2010-01-15       Impact factor: 6.937

9.  Identification and characterization of a novel non-structural protein of bluetongue virus.

Authors:  Maxime Ratinier; Marco Caporale; Matthew Golder; Giulia Franzoni; Kathryn Allan; Sandro Filipe Nunes; Alessia Armezzani; Amr Bayoumy; Frazer Rixon; Andrew Shaw; Massimo Palmarini
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

10.  Characterization of a second open reading frame in genome segment 10 of bluetongue virus.

Authors:  Meredith Stewart; Alexandra Hardy; Gerald Barry; Rute Maria Pinto; Marco Caporale; Eleonora Melzi; Joseph Hughes; Aislynn Taggart; Anna Janowicz; Mariana Varela; Maxime Ratinier; Massimo Palmarini
Journal:  J Gen Virol       Date:  2015-08-19       Impact factor: 3.891

  10 in total
  6 in total

1.  Putative Novel Atypical BTV Serotype '36' Identified in Small Ruminants in Switzerland.

Authors:  Christina Ries; Andrea Vögtlin; Daniela Hüssy; Tabea Jandt; Hansjörg Gobet; Monika Hilbe; Carole Burgener; Luzia Schweizer; Stephanie Häfliger-Speiser; Martin Beer; Bernd Hoffmann
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

2.  Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus.

Authors:  Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Ruymán Alonso-Ravelo; Eva Calvo-Pinilla; Alejandro Marín-López; Sandra Moreno; Gema Lorenzo; Julio Benavides; Sarah Gilbert; Aitor Nogales; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2020-06-29

3.  Bluetongue in India: a systematic review and meta-analysis with emphasis on diagnosis and seroprevalence.

Authors:  Ramkumar N Rupner; O R VinodhKumar; R Karthikeyan; D K Sinha; K P Singh; Z B Dubal; Shikha Tamta; V K Gupta; B R Singh; Y S Malik; K Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

4.  Development of real-time RT-qPCR assays for the typing of two novel bluetongue virus genotypes derived from sheeppox vaccine.

Authors:  Simon King; John Flannery; Carrie Batten; Paulina Rajko-Nenow
Journal:  J Virol Methods       Date:  2021-09-15       Impact factor: 2.014

5.  BTV-14 Infection in Sheep Elicits Viraemia with Mild Clinical Symptoms.

Authors:  John Flannery; Lorraine Frost; Petra Fay; Hayley Hicks; Mark Henstock; Marcin Smreczak; Anna Orłowska; Paulina Rajko-Nenow; Karin Darpel; Carrie Batten
Journal:  Microorganisms       Date:  2020-06-13

6.  Characterisation of Peste Des Petits Ruminants Disease in Pastoralist Flocks in Ngorongoro District of Northern Tanzania and Bluetongue Virus Co-Infection.

Authors:  Bryony Anne Jones; Mana Mahapatra; Chobi Chubwa; Brian Clarke; Carrie Batten; Hayley Hicks; Mark Henstock; Julius Keyyu; Richard Kock; Satya Parida
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.